Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

Amgen Inc

10 posts
NNovartis
Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race
Read More

Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race

  • 2026-09-08
Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a…
NNovartis
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
Read More

Amgen Shares Fall as Novartis’ Pelacarsen Misses Phase III Study Goal

  • 2026-09-07
Shares of Amgen AMGN were down 5% in after-hours trading on Friday after Novartis NVS announced that the…
NNovartis
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
Read More

Amgen Shares Fall as Novartis’ Pelacarsen Misses Phase III Study Goal

  • 2026-09-07
Shares of Amgen AMGN were down 5% in after-hours trading on Friday after Novartis NVS announced that the…
RRoche
Zacks Investment Research
Read More

Are Biosimilars Becoming a Key Pillar of Amgen’s Growth Story?

  • 2026-06-23
Historically known for its innovative biologic medicines such as Enbrel, Prolia and Repatha, AmgenAMGN has also emerged as…
NNovartis
Lp(a) drugs from Novartis, Amgen and Eli Lilly aim to prevent heart attacks
Read More

Lp(a) drugs from Novartis, Amgen and Eli Lilly aim to prevent heart attacks

  • 2026-04-27
Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among…
RRoche
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
Read More

The Zacks Analyst Blog Roche Holding, AT&T and Amgen

  • 2026-03-31
Chicago, IL – March 31, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
RRoche
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
Read More

The Zacks Analyst Blog Roche Holding, AT&T and Amgen

  • 2026-03-31
Chicago, IL – March 31, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
RRoche
Top Stock Reports for Roche, AT&T & Amgen
Read More

Top Stock Reports for Roche, AT&T & Amgen

  • 2026-03-30
Monday, March 30, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today’s…
RRoche
Novartis, Roche could be most at risk
Read More

Novartis, Roche could be most at risk

  • 2026-02-14
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer…
RRoche
Roche, Zealand Pharma's $5.3 billion obesity drug bet
Read More

Roche, Zealand Pharma’s $5.3 billion obesity drug bet

  • 2026-02-14
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News…
Switzerland
www.europesays.com